165 related articles for article (PubMed ID: 30616151)
1. Relationship between N,N-dimethylformamide exposure, PNPLA3, GCKR, COL13A1 and TM6SF2 genes, and liver injury.
Zhang X; Jiang H; Shen J; Zhang Y; Gu Y; Xiao J; Lian Y
Ecotoxicol Environ Saf; 2019 Apr; 171():347-351. PubMed ID: 30616151
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose N,N-Dimethylformamide Exposure and Liver Injuries in a Cohort of Chinese Leather Industry Workers.
Qi C; Gu Y; Sun Q; Gu H; Xu B; Gu Q; Xiao J; Lian Y
J Occup Environ Med; 2017 May; 59(5):434-439. PubMed ID: 28368964
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
6. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Benchmark Dose Study for N, N-Dimethylformamide Induced Liver Injury in a Chinese Occupational Cohort.
Wu Z; Liu Q; Wang C; Xu B; Guan M; Ye M; Jiang H; Zheng M; Zhang M; Zhao W; Jiang X; Leng S; Cheng J
Toxicol Sci; 2017 Jul; 158(1):140-150. PubMed ID: 28505332
[TBL] [Abstract][Full Text] [Related]
8. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
Shang XR; Song JY; Liu FH; Ma J; Wang HJ
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
[TBL] [Abstract][Full Text] [Related]
9. Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury.
Jiang H; Zhang X; Shen J; Zhang Y; Gu Y; Tian T; Chu M; Zhuang X; Lian Y
Int Arch Occup Environ Health; 2019 Oct; 92(7):967-975. PubMed ID: 30993423
[TBL] [Abstract][Full Text] [Related]
10. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
Sliz E; Sebert S; Würtz P; Kangas AJ; Soininen P; Lehtimäki T; Kähönen M; Viikari J; Männikkö M; Ala-Korpela M; Raitakari OT; Kettunen J
Hum Mol Genet; 2018 Jun; 27(12):2214-2223. PubMed ID: 29648650
[TBL] [Abstract][Full Text] [Related]
11. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
[TBL] [Abstract][Full Text] [Related]
12. Serum activities of liver enzymes in workers exposed to sub-TLV levels of dimethylformamide.
He J; Liu J; Kong Y; Yang W; Zhang Z
Int J Occup Med Environ Health; 2015; 28(2):395-8. PubMed ID: 26182934
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.
Grove JI; Thiagarajan P; Astbury S; Harris R; Delahooke T; Guha IN; Aithal GP
Liver Int; 2018 Oct; 38(10):1832-1838. PubMed ID: 29493856
[TBL] [Abstract][Full Text] [Related]
14. The deleterious effects of N,N-dimethylformamide on liver: A mini-review.
Li MJ; Zeng T
Chem Biol Interact; 2019 Jan; 298():129-136. PubMed ID: 30576622
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
[TBL] [Abstract][Full Text] [Related]
16. Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease.
Zhou Z; Sang L; Wang J; Song L; Zhu L; Wang Y; Xiao J; Lian Y
Ecotoxicol Environ Saf; 2021 Nov; 228():112986. PubMed ID: 34794021
[TBL] [Abstract][Full Text] [Related]
17. Abnormal liver function associated with occupational exposure to dimethylformamide and glutathione S-transferase polymorphisms.
Luo JC; Cheng TJ; Kuo HW; Chang MJ
Biomarkers; 2005; 10(6):464-74. PubMed ID: 16308270
[TBL] [Abstract][Full Text] [Related]
18. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
19. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
Petta S; Miele L; Bugianesi E; Cammà C; Rosso C; Boccia S; Cabibi D; Di Marco V; Grimaudo S; Grieco A; Pipitone RM; Marchesini G; Craxì A
PLoS One; 2014; 9(2):e87523. PubMed ID: 24498332
[TBL] [Abstract][Full Text] [Related]
20. The relationship among GNB3 rs5443, PNPLA3 rs738409, GCKR rs780094 gene polymorphisms, type of maternal gestational weight gain and neonatal outcomes (STROBE-compliant article).
Mărginean C; Mărginean CO; Bănescu C; Meliţ LE; Tripon F; Iancu M
Medicine (Baltimore); 2019 Jul; 98(28):e16414. PubMed ID: 31305457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]